Print

Accelr8 Technology Corporation (AXK) Presents Two Studies at American Society for Microbiology 2012 and Receives Acceptance to Present a New Blood Study  
6/22/2012 10:13:22 AM

DENVER--(BUSINESS WIRE)--Accelr8 Technology Corporation (NYSE MKT: AXK) announced results of two studies that it presented at the 112th annual General Meeting of the American Society for Microbiology (www.asm.org).
//-->